109 related articles for article (PubMed ID: 17943155)
1. Hemoglobin level in dialysis patients: revisiting the normal hematocrit study.
Singh AK
Kidney Int; 2007 Nov; 72(9):1161; author reply 1161-2. PubMed ID: 17943155
[No Abstract] [Full Text] [Related]
2. Hemoglobin variability as a predictor of mortality: What's a practitioner to do?
Wish JB
Am J Kidney Dis; 2011 Feb; 57(2):190-3. PubMed ID: 21251539
[No Abstract] [Full Text] [Related]
3. Can we improve the quality of life for dialysis patients?
Kliger AS; Finkelstein FO
Am J Kidney Dis; 2009 Dec; 54(6):993-5. PubMed ID: 19932876
[No Abstract] [Full Text] [Related]
4. Hemoglobin variability and mortality: confounding by disease severity.
Weinhandl ED; Peng Y; Gilbertson DT; Bradbury BD; Collins AJ
Am J Kidney Dis; 2011 Feb; 57(2):255-65. PubMed ID: 20801571
[TBL] [Abstract][Full Text] [Related]
5. The normal HCT trial re-revisited: what were the actual findings?
Besarab A; Bolton WK; Nissenson AR; Schwab SJ
Kidney Int; 2012 Jul; 82(2):242; author reply 242-3. PubMed ID: 22743566
[No Abstract] [Full Text] [Related]
6. Target hemoglobin level for EPO therapy in CKD.
Parfrey PS
Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
[No Abstract] [Full Text] [Related]
7. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
Kalender B; Ozdemir AC; Koroglu G
Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
[TBL] [Abstract][Full Text] [Related]
8. Evidence for optimal hemoglobin targets in chronic kidney disease.
Navaneethan SD; Bonifati C; Schena FP; Strippoli GF
J Nephrol; 2006; 19(5):640-7. PubMed ID: 17136694
[TBL] [Abstract][Full Text] [Related]
9. A physician's perseverance uncovers problems in a key nephrology study.
Fishbane S; Wish JB
Kidney Int; 2012 Jul; 82(2):135-7. PubMed ID: 22743565
[TBL] [Abstract][Full Text] [Related]
10. Use of iron-dextran to replace iron losses in chronic hemodialysis patients.
Hendler ED; Solomon L
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():108-12. PubMed ID: 756029
[No Abstract] [Full Text] [Related]
11. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
Foley RN; Curtis BM; Parfrey PS
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
[TBL] [Abstract][Full Text] [Related]
12. The effect of hemodialysis on intraerythrocytic phosphate compounds and oxygen binding to hemoglobin.
Lichtman MA
Kidney Int Suppl; 1975 Jan; (2):134-7. PubMed ID: 240059
[No Abstract] [Full Text] [Related]
13. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
Berns JS
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):567-72. PubMed ID: 20601876
[TBL] [Abstract][Full Text] [Related]
14. Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: con.
Himmelfarb J; Szczech LA
J Am Soc Nephrol; 2009 Jul; 20(7):1441-3. PubMed ID: 19579287
[No Abstract] [Full Text] [Related]
15. Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management.
Gallagher MP; Cass A; Craig JC
Nephrology (Carlton); 2010 Jun; 15(4):429-33. PubMed ID: 20609094
[TBL] [Abstract][Full Text] [Related]
16. The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
Singh AK
Clin J Am Soc Nephrol; 2010 Apr; 5(4):553-6. PubMed ID: 20203166
[No Abstract] [Full Text] [Related]
17. Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE; Szczech LA
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
[TBL] [Abstract][Full Text] [Related]
18. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
KDOQI
Am J Kidney Dis; 2007 Sep; 50(3):471-530. PubMed ID: 17720528
[No Abstract] [Full Text] [Related]
19. Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results.
Locatelli F; Covic A; Macdougall IC; Scherhag A; Wiecek A;
J Nephrol; 2009; 22(5):662-74. PubMed ID: 19810000
[TBL] [Abstract][Full Text] [Related]
20. Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha.
Furuland H; Linde T; Sandhagen B; Andrén B; Wikström B; Danielson BG
Scand J Urol Nephrol; 2005; 39(5):399-404. PubMed ID: 16257842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
